171 related articles for article (PubMed ID: 22992831)
1. PEGylated multi-walled carbon nanotubes for encapsulation and sustained release of oxaliplatin.
Wu L; Man C; Wang H; Lu X; Ma Q; Cai Y; Ma W
Pharm Res; 2013 Feb; 30(2):412-23. PubMed ID: 22992831
[TBL] [Abstract][Full Text] [Related]
2. Development of a controlled-release drug delivery system by encapsulating oxaliplatin into SPIO/MWNT nanoparticles for effective colon cancer therapy and magnetic resonance imaging.
Lee PC; Lin CY; Peng CL; Shieh MJ
Biomater Sci; 2016 Nov; 4(12):1742-1753. PubMed ID: 27722406
[TBL] [Abstract][Full Text] [Related]
3. Sustained Release of Mitomycin C from Its Conjugate with Single-Walled Carbon Nanotubes Associated by Pegylated Peptide.
Ohta T; Hashida Y; Yamashita F; Hashida M
Biol Pharm Bull; 2016; 39(10):1687-1693. PubMed ID: 27725447
[TBL] [Abstract][Full Text] [Related]
4. PEGylated multi-walled carbon nanotubes as versatile vector for tumor-specific intracellular triggered release with enhanced anti-cancer efficiency: Optimization of length and PEGylation degree.
Zhao X; Tian K; Zhou T; Jia X; Li J; Liu P
Colloids Surf B Biointerfaces; 2018 Aug; 168():43-49. PubMed ID: 29482875
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study on conjugation of formononetin with multiwalled carbon nanotubes for inducing apoptosis via ROS production in HeLa cells.
Guo B; Liao C; Liu X; Yi J
Drug Des Devel Ther; 2018; 12():2815-2826. PubMed ID: 30233144
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of cisplatin into PEG-wrapped ultrapurified large-inner-diameter MWCNTs for enhanced loading efficiency and release profile.
Sui L; Yang T; Gao P; Meng A; Wang P; Wu Z; Wang J
Int J Pharm; 2014 Aug; 471(1-2):157-65. PubMed ID: 24853461
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterisation and biological evaluation of biopolymer-coated multi-walled carbon nanotubes for sustained-delivery of silibinin.
Tan JM; Bullo S; Fakurazi S; Hussein MZ
Sci Rep; 2020 Oct; 10(1):16941. PubMed ID: 33037287
[TBL] [Abstract][Full Text] [Related]
8. PEGylated PAMAM dendrimers loading oxaliplatin with prolonged release and high payload without burst effect.
Ho MN; Bach LG; Nguyen DH; Nguyen CH; Nguyen CK; Tran NQ; Nguyen NV; Hoang Thi TT
Biopolymers; 2019 Jul; 110(7):e23272. PubMed ID: 30897210
[TBL] [Abstract][Full Text] [Related]
9. PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity.
Kim TH; Jiang HH; Park CW; Youn YS; Lee S; Chen X; Lee KC
J Control Release; 2011 Feb; 150(1):63-9. PubMed ID: 21062635
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of PEGylated multiwall carbon nanotubes as covalently conjugated and non-covalent drug carrier: A comparative study.
Rostamizadeh K; Habibizadeh M; Dalali N; Ramazani A
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():1-9. PubMed ID: 28254271
[TBL] [Abstract][Full Text] [Related]
11. The co-delivery of oxaliplatin abrogates the immunogenic response to PEGylated siRNA-lipoplex.
Alaaeldin E; Abu Lila AS; Moriyoshi N; Sarhan HA; Ishida T; Khaled KA; Kiwada H
Pharm Res; 2013 Sep; 30(9):2344-54. PubMed ID: 23673556
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitrogen-doped multi-walled carbon nanotubes compared to pristine multi-walled carbon nanotubes on human small airway epithelial cells.
Mihalchik AL; Ding W; Porter DW; McLoughlin C; Schwegler-Berry D; Sisler JD; Stefaniak AB; Snyder-Talkington BN; Cruz-Silva R; Terrones M; Tsuruoka S; Endo M; Castranova V; Qian Y
Toxicology; 2015 Jul; 333():25-36. PubMed ID: 25797581
[TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.
Zeghari-Squalli N; Raymond E; Cvitkovic E; Goldwasser F
Clin Cancer Res; 1999 May; 5(5):1189-96. PubMed ID: 10353756
[TBL] [Abstract][Full Text] [Related]
14. Mouse pulmonary dose- and time course-responses induced by exposure to nitrogen-doped multi-walled carbon nanotubes.
Porter DW; Orandle M; Zheng P; Wu N; Hamilton RF; Holian A; Chen BT; Andrew M; Wolfarth MG; Battelli L; Tsuruoka S; Terrones M; Castranova V
Inhal Toxicol; 2020 Jan; 32(1):24-38. PubMed ID: 32028803
[No Abstract] [Full Text] [Related]
15. The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines.
Xu JM; Azzariti A; Colucci G; Paradiso A
Cancer Chemother Pharmacol; 2003 Dec; 52(6):442-8. PubMed ID: 13680161
[TBL] [Abstract][Full Text] [Related]
16. The targeted delivery of anticancer drugs to brain glioma by PEGylated oxidized multi-walled carbon nanotubes modified with angiopep-2.
Ren J; Shen S; Wang D; Xi Z; Guo L; Pang Z; Qian Y; Sun X; Jiang X
Biomaterials; 2012 Apr; 33(11):3324-33. PubMed ID: 22281423
[TBL] [Abstract][Full Text] [Related]
17. Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.
Lay CL; Liu HQ; Tan HR; Liu Y
Nanotechnology; 2010 Feb; 21(6):065101. PubMed ID: 20057024
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin.
Yoong SL; Wong BS; Zhou QL; Chin CF; Li J; Venkatesan T; Ho HK; Yu V; Ang WH; Pastorin G
Biomaterials; 2014 Jan; 35(2):748-59. PubMed ID: 24140044
[TBL] [Abstract][Full Text] [Related]
19. Multi-walled carbon nanotubes functionalized with pyrene-PEG via π-π interactions: toxicological assessment in zebrafish embryos.
Cordeiro MF; Gomides LS; Vian CO; Carboni MT; Santos AP; Bruch GE; Horn AP; Barros DM
Nanotechnology; 2020 Nov; 31(46):465103. PubMed ID: 32857732
[TBL] [Abstract][Full Text] [Related]
20. Diameter-dependent release of a cisplatin pro-drug from small and large functionalized carbon nanotubes.
Muzi L; Ménard-Moyon C; Russier J; Li J; Chin CF; Ang WH; Pastorin G; Risuleo G; Bianco A
Nanoscale; 2015 Mar; 7(12):5383-94. PubMed ID: 25727105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
